Status and phase
Conditions
Treatments
About
The study is designed for multi-center,randomized,double-masked,active-contralled study to evaluate effective and security of intravitreal injection of IBI302 in subjects with neovascular age-related macular degeneration.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Ocular disease:
Ocular treatment:
General condition or treatment:
Primary purpose
Allocation
Interventional model
Masking
600 participants in 2 patient groups
Loading...
Central trial contact
Yating Liu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal